The FDA proposed in April 2026 to exclude semaglutide and tirzepatide from the 503B compounding bulks list - a development with real program availability implications that needs a direct answer from IVY RX before you commit to a multi-month plan
Enhances Insulin Sensitivity: GLP-1 improves insulin sensitivity, particularly in muscle tissue, allowing cells to utilize glucose more efficiently for energy rather than storing it as fat
We also have a dedicated pediatric emergency room, specifically designed to treat children
Included to help replenish nutrients affected by reduced appetite, not as a weight-loss treatment
Last Published 02.01.2026 Effective Date: 02.01.2026 This policy addresses breast imaging, including digital mammography, magnetic resonance imaging (MRI), ultrasound, automated breast ultrasound system, computer-aided detection (CAD), computer-aided tactile breast imaging, electrical impedance scanning (EIS), magnetic resonance elastography (MRE), and molecular breast imaging
